The National Rheumatoid Arthritis Society (NRAS) is running a new Work Survey and is pleased to be collaborating with the Centre for Musculoskeletal Research at the University of Manchester.
The Work Survey will investigate the experiences of people with Rheumatoid Arthritis (RA) and Adult Juvenile Idiopathic Arthritis (JIA), any impact it has had on your ability to work and how it affects you in the workplace.
The research comes 10 years after the publication of the ‘I Want to Work’ report and will enable NRAS to draw comparisons about any progress achieved over the last decade in relation to work, health and disability.…
Read more of this article
On the 26th May 2017, the British Society for Rheumatology released an important update to their most ‘in demand’ clinical guideline, on the Management of Gout. Gout is the most searched for term on the BSR website and it’s is a particularly painful form of arthritis which is becoming more common, yet continues to be poorly managed. 
Guest Blog by Neil Betteridge, co-chair, Chronic Pain Policy Coalition (CPPC)
15-18 February 2018 
Did you miss getting to the Rheumatology Conferences in 2016?
It’s been another productive month here at ARMA as I pass the three months in post milestone. With such a range of different activities there is never a dull moment. I have just attended my first ARMA Policy and Communications meeting. I enjoyed the lively discussions about joint messages on the importance of self-management and developing a co-ordinated social media plan for Bone and Joint Week in October. There is a lot of potential to support each other to have a bigger impact during the week.… 
On Monday 8th May 2017 the Scottish Medicines Consortium (SMC) published new advice accepting the restricted use of belimumab (Benlysta) by NHS Scotland for lupus patients. This advice was published following a re-submission with evidence supplied by GlaxoSmithKline (the producers of Benlysta) and LUPUS UK on behalf of patients.